Verrica Pharmaceuticals stock trades at USD 4.10

Published on 09/22/2026 at 18:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Verrica Pharmaceuticals stock traded at USD 4.10 on September 22, 2026, down 2.92 percent over 24 hours. Quarterly revenue reached USD 12.70 million.

VRCA, US92511P1021, Illustration mit AI erstellt.

Verrica Pharmaceuticals Inc. (ISIN US92511P1021) traded at USD 4.10 on Nasdaq on September 22, 2026, down 2.92 percent over 24 hours. The market capitalization was USD 38.82 million on the same date, giving the stock a clearly defined small-cap profile.

Quarterly revenue reaches USD 12.70 million

Verrica reported quarterly revenue of USD 12.70 million in the latest period shown by TradingView on September 22, 2026. That figure exceeded the displayed revenue estimate of USD 4.27 million by USD 8.43 million, a quantified difference of 197.4 percent versus the estimate.

The same quarterly data showed net income of USD 204,000, compared with a net loss of USD 9.74 million in the previous quarter. Quarterly earnings were USD 0.02 per share, versus an earlier estimate of a loss of USD 0.90 per share.

Losses still shape the valuation

The reported quarterly improvement does not remove the wider earnings risk. TradingView displayed trailing-twelve-month earnings per share of negative USD 8.30 and fiscal-year revenue of USD 7.57 million on September 22, 2026, while fiscal-year net income was negative USD 76.58 million.

For investors, the comparison between USD 12.70 million in quarterly revenue and USD 7.57 million in fiscal-year revenue is a reminder that the figures refer to different reporting periods and should not be treated as a single-period trend. The latest quarterly result is the more immediate operating datapoint, while the trailing and fiscal-year figures show the scale of accumulated losses.

Stock value remains highly compressed

At USD 4.10 on Nasdaq on September 22, 2026, Verrica Pharmaceuticals had a market capitalization of USD 38.82 million. The stock's displayed one-year performance was negative 70.92 percent, and its monthly change was negative 15.64 percent.

The next earnings date displayed in the market data was November 10, 2025, which is already historical relative to September 22, 2026 and therefore is not presented as a future reporting date. The dated market figures and the latest quarterly comparison instead provide the clearest measurable frame for VRCA stock.